Clinical trial
Safety and Clinical Performance of a Dialyzer With a Modified Polysulfone Membrane - eMPORA Study (Modified POlysulfone membRAne)
NCT03315624 is registered in ClinicalTrials.gov with Fresenius Medical Care Deutschland GmbH as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Safety and Clinical Performance of a Dialyzer With a Modified Polysulfone Membrane - eMPORA Study (Modified POlysulfone membRAne)
- Lead sponsor
- Fresenius Medical Care Deutschland GmbH
- Phase
- Not applicable
- Overall status
- Completed
- Start date
- October 6, 2017
- Completion date
- March 14, 2018
- Enrollment
- 49 (actual)
- Sites
- 1
Conditions
As the registry lists them; a condition with its own page is linked.
end stage renal disease, renal failure